Thyroid eye disease: towards an evidence base for treatment in the 21st century.

Current Neurology and Neuroscience Reports
Erin F GillespieRaymond S Douglas

Abstract

Thyroid eye disease (TED) is the most common extrathyroidal manifestation of Graves' disease. Incomplete understanding of its pathogenesis has hindered development of targeted therapies that might alter the natural course of disease. Smoking cessation and maintenance of euthyroidism appear to reduce the rate of onset and severity of TED. Recent evidence suggests that selenium may lessen the inflammatory symptoms in mild disease. Corticosteroids remain the primary treatment for patients with moderate to severe active TED. Surgical decompression is commonly undertaken in the chronic stable phase, and only rarely in the active phase when vision is threatened by compressive optic neuropathy. Orbital radiotherapy remains an adjunctive strategy during active disease. Targeted immunotherapies have the potential to alter disease progression, but further evidence is needed to establish safety and efficacy. In this article, we review evidence from prospective therapeutic trials of several treatment modalities. We focus on moderate to severe active TED.

References

May 1, 1990·Archives of Internal Medicine·M F PrummelR van der Gaag
Nov 16, 1989·The New England Journal of Medicine·M F PrummelW M Wiersinga
Aug 1, 1989·The British Journal of Ophthalmology·M P MouritsR van der Gaag
Sep 1, 1988·Journal of Endocrinological Investigation·W M WiersingaL Koornneef
Aug 1, 1973·The Journal of Clinical Endocrinology and Metabolism·S S DonaldsonJ P Kriss
May 1, 1994·The American Journal of Cardiology·Y AdlerY Shoenfeld
Sep 1, 1996·The Journal of Clinical Endocrinology and Metabolism·A SoriskyT J Smith
Nov 1, 1996·Clinical and Experimental Immunology·G KahalyG Hommel
Aug 1, 1997·Thyroid : Official Journal of the American Thyroid Association·L BaschieriP Fallahi
Jan 8, 1998·The New England Journal of Medicine·L BartalenaA Pinchera
Oct 24, 1998·Annals of Internal Medicine·L BartalenaA Pinchera
Apr 27, 2000·Endocrine Reviews·L BartalenaC Marcocci
Feb 7, 2001·The Journal of Clinical Endocrinology and Metabolism·T H BrixL Hegedüs
Apr 21, 2001·Journal of Endocrinological Investigation·P E MacchiaG Fenzi
Nov 8, 2001·International Journal of Radiation Oncology, Biology, Physics·S D MarquezS S Donaldson
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Ulrich SchaeferNormann Willich
Feb 9, 2002·European Journal of Endocrinology·Peter Vestergaard
Feb 14, 2002·Seminars in Oncology·David G MaloneyAndrea Rose
May 16, 2002·Current Rheumatology Reports·Yair Molad
May 29, 2003·The British Journal of Ophthalmology·A EcksteinJ Esser
Aug 14, 2003·The Journal of Clinical Endocrinology and Metabolism·Claudio MarcocciAldo Pinchera
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Mark F PrummelWilmar M Wiersinga
May 29, 2004·Journal of Endocrinological Investigation·W M WiersingaC B Terwee
May 29, 2004·Journal of Endocrinological Investigation·L HegediüsP Vestergaard
Aug 4, 2004·Ophthalmology·Iris M M J WakelkampWilmar M Wiersinga
Oct 19, 2004·The British Journal of Ophthalmology·R EbnerH Niepomniszcze
Dec 8, 2004·The Journal of Clinical Endocrinology and Metabolism·A Jane DickinsonPat Kendall-Taylor
Jul 7, 2005·The Journal of Clinical Endocrinology and Metabolism·George J KahalyManuela Dittmar
Jun 24, 2006·Journal of Endocrinological Investigation·T-C Chang, S-L Liao

❮ Previous
Next ❯

Citations

Apr 25, 2014·Ophthalmic Plastic and Reconstructive Surgery·Chad M BinghamJennifer A Sivak-Callcott
Jul 11, 2013·Current Opinion in Otolaryngology & Head and Neck Surgery·Eugene L Alford, Charles N S Soparkar
Apr 25, 2014·The Journal of Clinical Endocrinology and Metabolism·L ZhangM Ludgate
Dec 3, 2015·International Ophthalmology Clinics·Andrew J Victores, Masayoshi Takashima
Aug 5, 2017·Expert Review of Ophthalmology·Alexander D BlandfordJulian D Perry
Jan 24, 2021·Clinical & Experimental Ophthalmology·Amy P JainRaymond S Douglas
Jan 29, 2021·Investigative Ophthalmology & Visual Science·Christine L HammondCollynn F Woeller
Mar 21, 2021·International Ophthalmology Clinics·Aimee C ChangBobby S Korn
Aug 5, 2019·American Journal of Ophthalmology·Amy PatelRaymond S Douglas
Apr 15, 2021·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·Yizhi DingHua Gao
Apr 29, 2021·Facial Plastic Surgery Clinics of North America·Hannah LandsbergerRaymond S Douglas
Jul 11, 2021·Eye·Shoaib UgradarRaymond S Douglas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society
Dawn D YangVikram D Durairaj
© 2022 Meta ULC. All rights reserved